Search Results - "Crola Da Silva, C"

Refine Results
  1. 1

    Protection of Human Pancreatic Islets from Lipotoxicity by Modulation of the Translocon by Cassel, R, Ducreux, S, Alam, M R, Dingreville, F, Berlé, C, Burda-Jacob, K, Chauvin, M A, Chikh, K, Païta, L, Al-Mawla, R, Crola Da Silva, C, Rieusset, J, Thivolet, C, Van Coppenolle, F, Madec, A M

    Published in PloS one (10-02-2016)
    “…Type 2 diabetes is characterized by peripheral insulin resistance and pancreatic beta cell dysfunction. Elevated free fatty acids (FFAs) may impair beta cell…”
    Get full text
    Journal Article
  2. 2

    The SR/ER-mitochondria calcium crosstalk is regulated by GSK3β during reperfusion injury by Gomez, L, Thiebaut, P-A, Paillard, M, Ducreux, S, Abrial, M, Crola Da Silva, C, Durand, A, Alam, M R, Van Coppenolle, F, Sheu, S-S, Ovize, M

    Published in Cell death and differentiation (01-02-2016)
    “…Glycogen synthase kinase-3 β (GSK3 β ) is a multifunctional kinase whose inhibition is known to limit myocardial ischemia–reperfusion injury. However, the…”
    Get full text
    Journal Article
  3. 3

    Inhibition of myocardial reperfusion injury by ischemic postconditioning requires sirtuin 3-mediated deacetylation of cyclophilin D by Bochaton, T, Crola-Da-Silva, C, Pillot, B, Villedieu, C, Ferreras, L, Alam, M.R, Thibault, H, Strina, M, Gharib, A, Ovize, M, Baetz, D

    “…Abstract Rationale . How ischemic postconditioning can inhibit opening of the mitochondrial permeability transition pore (PTP) and subsequent cardiac myocytes…”
    Get full text
    Journal Article
  4. 4

    The influence of early post-STEMI inflammation on diastolic function: diagnostic and therapeutic implications by Filip, S, Leboube, S, Thibault, H, Bergerot, C, Paccalaet, A, Hayek, A, Rioufol, G, Bonnefoy-Cudraz, E, Prieur, C, Crola Da Silva, C, Brun, C, Mewton, N, Mechtouff, L, Bochaton, T

    Published in European heart journal (09-11-2023)
    “…Abstract Introduction We know that diastolic dysfunction (DD) after ST elevation myocardial infarction (STEMI) is associated with patients prognosis. Systolic…”
    Get full text
    Journal Article
  5. 5

    Phosphorylation of cyclophilin D at serine 191 regulates mitochondrial permeability transition pore opening and cell death after ischemia-reperfusion by Hurst, Stephen, Gonnot, Fabrice, Dia, Maya, Crola Da Silva, Claire, Gomez, Ludovic, Sheu, Shey-Shing

    Published in Cell death & disease (19-08-2020)
    “…The mitochondrial permeability transition pore (mPTP) plays a critical role in the pathogenesis of cardiovascular diseases, including ischemia/reperfusion…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Heat Shock Protein 70 as a Biomarker of Clinical Outcomes After STEMI by Bochaton, Thomas, Paccalet, Alexandre, Jeantet, Pierre, Crola Da Silva, Claire, Cartier, Régine, Prieur, Cyril, Jossan, Claire, Bonnefoy-Cudraz, Eric, Mewton, Nathan, Ovize, Michel

    “…From 2016 to 2018, we prospectively enrolled in our hospital 251 consecutive patients with STEMI who underwent percutaneous coronary intervention (PCI)…”
    Get full text
    Journal Article
  9. 9

    IL-10 / IL-6 serum ratio as a prognosis marker of STEMI by Leboube, S, Bochaton, T, Paccalet, A, Crola Da Silva, C, Jeantet, P, Amaz, C, De Bourguignon, C, Varillon, Y, Prieur, C, Tomasevic, D, Genot, N, Rioufol, G, Bonnefoy-Cudraz, E, Mewton, N, Ovize, M

    Published in European heart journal (01-11-2020)
    “…Abstract Introduction IL-6 and IL-10 are two major cytokines secreted at the acute phase of myocardial infarction (MI). IL-6 has a pro-inflammatory effect…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20

    The SR/ER-mitochondria calcium crosstalk is regulated by GSK3[beta] during reperfusion injury by Gomez, L, Thiebaut, P-a, Paillard, M, Ducreux, S, Abrial, M, Crola Da Silva, C, Durand, A, Alam, M R, Van Coppenolle, F, Sheu, S-s, Ovize, M

    Published in Cell death and differentiation (01-02-2016)
    “…Glycogen synthase kinase-3β (GSK3β) is a multifunctional kinase whose inhibition is known to limit myocardial ischemia-reperfusion injury. However, the…”
    Get full text
    Journal Article